STOCK TITAN

Natus Chairperson Dr. Barbara Paul Retires; Board Elects Current Board Member Joshua Levine as Chairperson

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management
Rhea-AI Summary

Natus Medical Incorporated (NASDAQ:NTUS) announced the retirement of Dr. Barbara Paul as Chairperson of the Board effective June 30, 2021, after five years of service. Joshua Levine, an independent director since 2018, has been appointed as the new Chairperson. CEO Jonathan Kennedy praised Dr. Paul for her instrumental role in the company's transformation and acknowledged her contributions in guiding Natus. Dr. Paul's retirement was described as amicable, with no disagreements reported with the company or its management.

Positive
  • Joshua Levine's appointment may bring new perspectives to the board.
  • Dr. Paul's leadership contributed to the company's transformation.
Negative
  • Dr. Paul's departure may raise concerns about continuity in leadership.

PLEASANTON, Calif., June 28, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced Dr. Barbara Paul, the Chairperson of the Board of Directors will retire from the Board effective June 30, 2021. The Board has elected independent director Joshua Levine who has served on the Natus board since 2018 as the new Chairperson.

Jonathan Kennedy, President and Chief Executive Officer of Natus, said, “Barbara played an instrumental role on our board over the past five years, helping to guide the One Natus transformation. Barbara’s experience as a healthcare provider has proven to be valuable to all our stakeholders and we are a stronger company as a result of her contributions. Barbara’s guidance and counsel will be missed, and I am grateful for her service.”

“I have appreciated and enjoyed the opportunity to serve on Natus’ board, and am proud of the collective achievements and significant progress made by the Company over the past five years. It has been my privilege to serve as board chair,” said Dr. Paul.

“I am grateful for the trust of my fellow board members in appointing me to this leadership position. I want to thank Dr. Paul for her service and leadership of the board,” said Joshua Levine, Natus’ new Chairperson of the Board of Directors.

Dr. Paul’s decision to retire from the Board after five years of distinguished service did not result from any disagreement with the Company or its management.

About Natus Medical Incorporated

Natus is a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. Additional information about Natus Medical can be found at www.natus.com.

Natus Medical Incorporated
B. Drew Davies
Executive Vice President and Chief Financial Officer
(925) 223-6700
InvestorRelations@Natus.com


FAQ

What led to Dr. Barbara Paul's retirement from Natus Medical?

Dr. Barbara Paul retired from Natus Medical after five years of service, and her decision was amicable with no disagreements reported with the management.

Who is the new Chairperson of Natus Medical's Board of Directors?

Joshua Levine has been elected as the new Chairperson effective June 30, 2021.

What impact might the leadership change have on Natus Medical?

The leadership change could bring fresh perspectives and strategies, helping to guide Natus Medical in its ongoing transformation.

How long did Dr. Barbara Paul serve as Chairperson of Natus Medical?

Dr. Barbara Paul served as Chairperson of Natus Medical for five years.

NTUS

NASDAQ:NTUS

NTUS Rankings

NTUS Latest News

NTUS Stock Data

1.14B
33.91M
1.95%
95.2%
4.23%
Medical Devices
Healthcare
Link
United States
Middleton